[
  {
    "": 1,
    "__1": "acetaminophen",
    "__2": "Tylenol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: acetaminophen\nBrand Example: Tylenol\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 2,
    "__1": "acetyl l-carnitine",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: acyclovir\nBrand Example: Zovirax\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antivirals\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 3,
    "__1": "acyclovir",
    "__2": "Zovirax",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: acyclovir\nBrand Example: Zovirax\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antivirals\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 4,
    "__1": "adalimumab",
    "__2": "Humira",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: adalimumab\nBrand Example: Humira\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable \nDrug Class: Analgesics – Analgesics – Anti-Inflammatory (TNF – alpha blocker)\nReference in ACOEM Guidelines: \nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable\nUnique Pharmaceutical Identifier (s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 5,
    "__1": "albuterol sulfate",
    "__2": "Proventil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 14, 2024) \nDrug Formulary \nDrug Ingredient: albuterol sulfate\nBrand Example: Proventil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 6,
    "__1": "alcaftadine",
    "__2": "Lastacaft",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: alcaftadine\nBrand Example: Lastacaft\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 7,
    "__1": "alclometasone dipropionate",
    "__2": "Aclovate",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: alclometasone dipropionate\nBrand Example: Aclovate\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 8,
    "__1": "alendronate sodium",
    "__2": "Fosamax",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: alendronate sodium\nBrand Example: Fosamax\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines: \nChronic Pain: Recommended \nHip and Groin Disorders: Recommended, No Recommendation \nKnee Disorders: No Recommendation \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 9,
    "__1": "almotriptan malate",
    "__2": "Axert",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: almotriptan malate\nBrand Example: Axert\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 10,
    "__1": "alprazolam",
    "__2": "Xanax",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: alprazolam\nBrand Example: Xanax\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 11,
    "__1": "amantadine hcl",
    "__2": "Symmetrel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: amantadine hcl\nBrand Example: Symmetrel\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiparkinson Agents (NMDA receptor antagonist)\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nLow Back Disorders: Not Recommended \nTraumatic Brain Injury: Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 12,
    "__1": "amcinonide",
    "__2": "Cyclocort",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: amcinonide \nBrand Example: Cyclocort\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 13,
    "__1": "amitriptyline hcl",
    "__2": "Elavil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: amitriptyline hcl\nBrand Example: Elavil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation Post-Traumatic Stress Disorder: No Recommendation \nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "amoxapine",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: amoxapine\nBrand Example: Not Applicable\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nDepressive Disorders: Recommended\nDosage Form: Not applicable\nStrength: Not applicable\nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 14,
    "__1": "amlodipine besylate",
    "__2": "Norvasc",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: amlodipine besylate\nBrand Example: Norvasc\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Calcium Channel Blockers\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 15,
    "__1": "amoxicillin/clavulanate p",
    "__2": "Augmentin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: amoxicillin/clavulanate p\nBrand Example: Augmentin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nLow Back Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 16,
    "__1": "anakinra",
    "__2": "Kineret",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: anakinra \nBrand Example: Kineret\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-inflammatory\nReference in ACOEM Guidelines: Knee Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 17,
    "__1": "apixaban",
    "__2": "Eliquis",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: apixaban\nBrand Example: Eliquis\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: 14 Days \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 18,
    "__1": "aripiprazole",
    "__2": "Abilify",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: aripiprazole\nBrand Example: Abilify\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 days \nPeri-Op: Not Applicable \nDrug Class: Antipsychotic/Antimanic Agents \nReference in ACOEM Guidelines: \nPost-Traumatic Stress Disorder: No Recommendation\nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 19,
    "__1": "artificial tear ointments",
    "__2": "Refresh PM",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: artificial tear ointments \nBrand Example: Refresh PM\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Artificial Tears)\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 20,
    "__1": "ascorbic acid",
    "__2": "Vitamin C",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: ascorbic acid\nBrand Example: Vitamin C\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 21,
    "__1": "aspirin",
    "__2": "Bayer",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: aspirin\nBrand Example: Bayer\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 22,
    "__1": "aspirin/caffeine/dihydrocodeine bitartrate",
    "__2": "Synalgos-DC",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: aspirin/caffeine/dihydrocodeine bitartrate\nBrand Example: Synalgos-DC\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 23,
    "__1": "atenolol",
    "__2": "Tenormin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: atenolol\nBrand Example: Tenormin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Beta Blockers\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 24,
    "__1": "azelastine ophth",
    "__2": "Optivar",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: azelastine ophth\nBrand Example: Optivar\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 25,
    "__1": "azithromycin ophth",
    "__2": "Azasite",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: azithromycin ophth\nBrand Example: Azasite\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "atorvastatin calcium",
    "__2": "Lipitor",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: atorvastatin calcium\nBrand Example: Lipitor\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihyperlipidemic\nReference in ACOEM Guidelines: \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 26,
    "__1": "azithromycin",
    "__2": "Zithromax",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: azithromycin\nBrand Example: Zithromax\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines: NR: COVID-19; Hand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 27,
    "__1": "bacitracin",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: bacitracin\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 28,
    "__1": "baclofen",
    "__2": "Lioresal",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: baclofen\nBrand Example: Lioresal\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Not Recommended \nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 29,
    "__1": "becaplermin",
    "__2": "Regranex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: becaplermin \nBrand Example: Regranex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 30,
    "__1": "beclomethasone dipropionate",
    "__2": "Qvar",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: beclomethasone dipropionate\nBrand Example: Qvar\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 31,
    "__1": "bepotastine ophth",
    "__2": "Bepreve",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: bepotastine ophth\nBrand Example: Bepreve\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 32,
    "__1": "besifloxacin ophth",
    "__2": "Besivance",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: besifloxacin ophth\nBrand Example: Besivance\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Topical antibiotic\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 33,
    "__1": "betamethasone",
    "__2": "Celestone",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: betamethasone\nBrand Example: Celestone\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 34,
    "__1": "betamethasone dipropionat",
    "__2": "Diprosone",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: betamethasone dipropionat \nBrand Example: Diprosone\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 35,
    "__1": "betamethasone valerate",
    "__2": "Valisone",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: betamethasone valerate \nBrand Example: Valisone\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "brexpiprazole",
    "__2": "Rexulti",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: brexpiprazole\nBrand Example: Rexulti\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: Not Applicable \nDrug Class: Antipsychotics /Antimanic Agents\nReference in ACOEM Guidelines: Depressive Disorders: Recommended"
  },
  {
    "": 36,
    "__1": "boswellia serrata extract",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: boswellia serrata extract\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 37,
    "__1": "bromfenac",
    "__2": "Prolensa",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: bromfenac\nBrand Example: Prolensa\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 38,
    "__1": "bromocriptine mesylate",
    "__2": "Parlodel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: bromocriptine mesylate\nBrand Example: Parlodel\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiparkinson and Related Therapy Agents\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 39,
    "__1": "budesonide",
    "__2": "Pulmicort",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: budesonide\nBrand Example: Pulmicort\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 40,
    "__1": "budesonide/formoterol",
    "__2": "Symbicort",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: budesonide/formoterol\nBrand Example: Symbicort\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 41,
    "__1": "buprenorphine (hcl)",
    "__2": "Butrans",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: buprenorphine (hcl)\nBrand Example: Butrans\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 42,
    "__1": "buprenorphine hcl/naloxone",
    "__2": "Suboxone",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: buprenorphine hcl/naloxone\nBrand Example: Suboxone\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 43,
    "__1": "bupropion hcl",
    "__2": "Wellbutrin, Wellbutrin XL, Wellbutrin SR",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: bupropion hcl\nBrand Example: Wellbutrin, Wellbutrin XL, Wellbutrin SR\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 44,
    "__1": "butalbital/apap/caffeine",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: butalbital/apap/caffeine\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 45,
    "__1": "butalbital/asa/caffeine",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: butalbital/asa/caffeine\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 46,
    "__1": "butenafine hcl",
    "__2": "Lotrimin Ultra",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: butenafine hcl \nBrand Example: Lotrimin Ultra\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 47,
    "__1": "butorphanol tartrate",
    "__2": "Stadol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: butorphanol tartrate\nBrand Example: Stadol\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 48,
    "__1": "cabergoline",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cabergoline\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents - Misc.\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 49,
    "__1": "calcitonin-salmon",
    "__2": "Fortical, Miacalcin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: calcitonin-salmon\nBrand Example: Fortical, Miacalcin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 50,
    "__1": "calcium phosphate tribasic",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: calcium phosphate tribasic\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Minerals and Electrolytes\nReference in ACOEM Guidelines: Ankle and Foot Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 51,
    "__1": "camphor",
    "__2": "Bengay Ultra",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: camphor\nBrand Example: Bengay Ultra\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 52,
    "__1": "capsaicin",
    "__2": "Zostrix",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: capsaicin\nBrand Example: Zostrix\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals (Topical creams and ointments)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended \nChronic Pain: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 53,
    "__1": "carbamazepine",
    "__2": "Tegretol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: carbamazepine\nBrand Example: Tegretol\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 54,
    "__1": "carboxymethylcellulose sodium ophthalmic",
    "__2": "Refresh Plus",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: carboxymethylcellulose sodium ophthalmic\nBrand Example: Refresh Plus\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Artificial Tears)\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 55,
    "__1": "carisoprodol",
    "__2": "Soma",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: carisoprodol\nBrand Example: Soma\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 56,
    "__1": "cefadroxil",
    "__2": "Duracef",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cefadroxil\nBrand Example: Duracef\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Cephalosporins\nReference in ACOEM Guidelines: Hip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 57,
    "__1": "cefuroxime axetil",
    "__2": "Ceftin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cefuroxime axetil\nBrand Example: Ceftin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Cephalosporins)\nReference in ACOEM Guidelines: \nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 58,
    "__1": "celecoxib",
    "__2": "Celebrex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: celecoxib\nBrand Example: Celebrex\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended; Depressive Disorders: Not Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 59,
    "__1": "cephalexin",
    "__2": "Keflex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cephalexin\nBrand Example: Keflex\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Cephalosporins)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation \nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 60,
    "__1": "certolizumab pegol",
    "__2": "Cimzia",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: certolizumab pegol\nBrand Example: Cimzia\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Gastrointestinal Agents (TNF Blocker) \nReference in ACOEM Guidelines: \nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 61,
    "__1": "chlorzoxazone",
    "__2": "Lorzone, Parafon Forte",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: chlorzoxazone\nBrand Example: Lorzone, Parafon Forte\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 62,
    "__1": "choline magnesium trisalicylate",
    "__2": "Trilisate",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: choline magnesium trisalicylate\nBrand Example: Trilisate\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation \nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 63,
    "__1": "chondroitin sulfate",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: chondroitin sulfate\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines (OTC nutraceutical)\nReference in ACOEM Guidelines: \nHand, Wrist, and Forearm Disorders: No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 64,
    "__1": "ciclesonide",
    "__2": "Alvesco",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ciclesonide\nBrand Example: Alvesco\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 65,
    "__1": "ciclopirox olamine",
    "__2": "Loprox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ciclopirox olamine\nBrand Example: Loprox\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 66,
    "__1": "cimetidine",
    "__2": "Tagamet",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cimetidine\nBrand Example: Tagamet\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (H2 receptor blocker) \nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 67,
    "__1": "ciprofloxacin",
    "__2": "Cipro",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ciprofloxacin\nBrand Example: Cipro\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 68,
    "__1": "ciprofloxacin hcl ophthalmic",
    "__2": "Ciloxan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ciprofloxacin hcl ophthalmic\nBrand Example: Ciloxan\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 69,
    "__1": "citalopram hydrobromide",
    "__2": "Celexa",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: citalopram hydrobromide\nBrand Example: Celexa\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 70,
    "__1": "citicoline",
    "__2": "Ceraxon",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: citicoline\nBrand Example: Ceraxon\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 71,
    "__1": "clarithromycin",
    "__2": "Biaxin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: clarithromycin\nBrand Example: Biaxin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 72,
    "__1": "clindamycin hcl",
    "__2": "Cleocin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: clindamycin hcl\nBrand Example: Cleocin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 73,
    "__1": "clomipramine hcl",
    "__2": "Anafranil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: clomipramine hcl\nBrand Example: Anafranil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended; Depressive Disorders:  Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 74,
    "__1": "clonazepam",
    "__2": "Klonopin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: clonazepam\nBrand Example: Klonopin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nAnxiety: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 75,
    "__1": "clonidine",
    "__2": "Catapres TTS",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: clonidine\nBrand Example: Catapres TTS\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 76,
    "__1": "clonidine hcl",
    "__2": "Catapres",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: clonidine hcl\nBrand Example: Catapres\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic \nReference in ACOEM Guidelines: \nChronic Pain: Recommended, No Recommendation\nLow Back Disorders: Not Recommended, No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 77,
    "__1": "clotrimazole antifungal",
    "__2": "Lotrimin AF",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: clotrimazole antifungal\nBrand Example: Lotrimin AF\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 79,
    "__1": "codeine sulfate",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: codeine sulfate\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 80,
    "__1": "codeine/acetaminophen",
    "__2": "Tylenol #3, Tylenol #4",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: codeine/acetaminophen\nBrand Example: Tylenol number 3, Tylenol number 4\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 81,
    "__1": "coenzyme q10",
    "__2": "CoQ10",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: coenzyme q10\nBrand Example: CoQ10\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 82,
    "__1": "colchicine",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: colchicine\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Gout Agents\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 83,
    "__1": "cortisone",
    "__2": "Cortone",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: cortisone\nBrand Example: Cortone\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation \nShoulder: Recommended, Not Recommende\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 84,
    "__1": "creatine monohydrate",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: creatine monohydrate\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 85,
    "__1": "cromolyn sodium",
    "__2": "Intal",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cromolyn sodium\nBrand Example: Intal\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 86,
    "__1": "cromolyn sodium (opthalmic)",
    "__2": "Opticrom",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cromolyn sodium (opthalmic)\nBrand Example: Opticrom\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 87,
    "__1": "cyclobenzaprine hcl",
    "__2": "Flexeril",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: cyclobenzaprine hcl\nBrand Example: Flexeril\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 88,
    "__1": "cyclopentolate hcl",
    "__2": "Cyclogyl",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cyclopentolate hcl\nBrand Example: Cyclogyl\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines: Eye: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 89,
    "__1": "cyclosporine",
    "__2": "Sandimmune",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: cyclosporine\nBrand Example: Sandimmune\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Miscellaneous Therapeutic Classes\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 90,
    "__1": "dalteparin",
    "__2": "Fragmin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: dalteparin\nBrand Example: Fragmin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: No Recommendation \nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 91,
    "__1": "dantrolene sodium",
    "__2": "Dantrium",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dantrolene sodium\nBrand Example: Dantrium\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 92,
    "__1": "dehydroepiandrosterone (dhea)",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dehydroepiandrosterone (dhea)\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 93,
    "__1": "desipramine hcl",
    "__2": "Norpramin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: desipramine hcl\nBrand Example: Norpramin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended; Depressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 94,
    "__1": "desloratadine",
    "__2": "Clarinex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: desloratadine\nBrand Example: Clarinex\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 95,
    "__1": "desmopressin acetate",
    "__2": "DDAVP",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: desmopressin acetate\nBrand Example: DDAVP\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents - Misc.\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 96,
    "__1": "desonide",
    "__2": "Desowen",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: desonide\nBrand Example: Desowen\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 97,
    "__1": "desoximetasone",
    "__2": "Topicort",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: desoximetasone\nBrand Example: Topicort\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 98,
    "__1": "desvenlafaxine",
    "__2": "Khedezla",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: desvenlafaxine er\nBrand Example: Pristiq\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SNRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 99,
    "__1": "dexamethasone",
    "__2": "Decadron",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: dexamethasone\nBrand Example: Decadron\nExempt/Non-Exempt: Exempt\nSpecial Fill: NA\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended; (R) COVID-19 Coronavirus\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 100,
    "__1": "dexamethasone sodium phosphate ophthalmic",
    "__2": "Maxidex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dexamethasone sodium phosphate ophthalmic\nBrand Example: Maxidex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 101,
    "__1": "dexlansoprazole",
    "__2": "Dexilant",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dexlansoprazole\nBrand Example: Dexilant\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 102,
    "__1": "dextromethorphan",
    "__2": "Delsym",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dextromethorphan\nBrand Example: Delsym\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Cough/Cold/Allergy (NMDA Receptor Antagonist)\nReference in ACOEM Guidelines: \nChronic Pain: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 103,
    "__1": "dextromethorphan-quinidine sulfate",
    "__2": "Nuedexta",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dextromethorphan-quinidine sulfate\nBrand Example: Nuedexta\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents-Misc.\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 104,
    "__1": "diazepam",
    "__2": "Valium",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: diazepam\nBrand Example: Valium\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antianxiety Agents (Muscle relaxant)\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 105,
    "__1": "diclofenac potassium",
    "__2": "Cataflam",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: diclofenac potassium\nBrand Example: Cataflam\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: No Recommendation\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 106,
    "__1": "diclofenac sodium",
    "__2": "Voltaren",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: diclofenac sodium\nBrand Example: Voltaren\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Antiinflammatory\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: No Recommendation\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, No Recommendation \nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 107,
    "__1": "diclofenac sodium (topical)",
    "__2": "Voltaren 1% gel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: diclofenac sodium (topical)\nBrand Example: Voltaren 1 percent gel\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals \nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nShoulder: No Recommendation, Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 108,
    "__1": "diclofenac sodium ophthalmic",
    "__2": "Voltaren",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: diclofenac sodium ophthalmic\nBrand Example: Voltaren \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 109,
    "__1": "diclofenac sodium/misoprostol",
    "__2": "Arthrotec",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: diclofenac sodium/misoprostol\nBrand Example: Arthrotec\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID/ Ulcer drug)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended \nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "diclofenac epolamine",
    "__2": "Flector",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: diclofenac epolamine\nBrand Example: Flector\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: \nShoulder Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 110,
    "__1": "dicloxacillin sodium",
    "__2": "Dynapen",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dicloxacillin sodium\nBrand Example: Dynapen\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation \nHip and Groin Disorders: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 111,
    "__1": "diflunisal",
    "__2": "Dolobid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: diflunisal\nBrand Example: Dolobid\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 112,
    "__1": "dihydroergotamine mesylat",
    "__2": "Migranal",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dihydroergotamine mesylat\nBrand Example: Migranal\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 113,
    "__1": "dimethyl sulfoxide",
    "__2": "DMSO",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dimethyl sulfoxide\nBrand Example: DMSO\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Genitourinary - Misc. (Ointments and topical agents)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 114,
    "__1": "divalproex sodium",
    "__2": "Depakote",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: divalproex sodium\nBrand Example: Depakote\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended \nLow Back Disorders: No Recommendation \nPost-Traumatic Stress Disorder: Not Recommended \nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 115,
    "__1": "dolasetron mesylate",
    "__2": "Anzemet",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dolasetron mesylate\nBrand Example: Anzemet\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 116,
    "__1": "donepezil hcl",
    "__2": "Aricept",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: donepezil hcl\nBrand Example: Aricept\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents-Misc.\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 117,
    "__1": "doxazosin mesylate",
    "__2": "Cardura",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: doxazosin mesylate\nBrand Example: Cardura\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 118,
    "__1": "doxepin hcl",
    "__2": "Sinequan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: doxepin hcl\nBrand Example: Sinequan\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended; Depressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Not Recommended, Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 119,
    "__1": "doxycycline",
    "__2": "Vibramycin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: doxycycline\nBrand Example: Vibramycin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Tetracyclines)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 120,
    "__1": "duloxetine hcl",
    "__2": "Cymbalta",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: duloxetine hcl\nBrand Example: Cymbalta\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SNRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended; Depressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation \nKnee Disorders: Recommended, Not Recommended, No Recommendation \nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 121,
    "__1": "econazole nitrate",
    "__2": "Spectazole",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: econazole nitrate\nBrand Example: Spectazole\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 122,
    "__1": "edoxaban tosylate",
    "__2": "Savaysa",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: edoxaban tosylate\nBrand Example: Savaysa\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines: Hip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 123,
    "__1": "eletriptan hydrobromide",
    "__2": "Relpax",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: eletriptan hydrobromide\nBrand Example: Relpax\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 124,
    "__1": "emedastine ophth",
    "__2": "Emadine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: emedastine ophth\nBrand Example: Emadine\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 125,
    "__1": "enoxaparin sodium",
    "__2": "Lovenox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: enoxaparin sodium\nBrand Example: Lovenox\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 126,
    "__1": "epinastine hcl",
    "__2": "Elestat",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: epinastine hcl\nBrand Example: Elestat\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 127,
    "__1": "erythromycin",
    "__2": "Ery-Tab",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: erythromycin\nBrand Example: Ery-Tab\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 128,
    "__1": "erythromycin ophthalmic ointment",
    "__2": "Ilotycin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: erythromycin ophthalmic ointment\nBrand Example: Ilotycin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "esketamine",
    "__2": "Spravato",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: esketamine\nBrand Example: Spravato\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines: \nDepressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 129,
    "__1": "escitalopram oxalate",
    "__2": "Lexapro",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: escitalopram oxalate\nBrand Example: Lexapro\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Recommended, Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Recommended, Not Recommended\n Low Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended \nShoulder: Not Recommended, Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 130,
    "__1": "esomeprazole magnesium",
    "__2": "Nexium",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: esomeprazole magnesium \nBrand Example: Nexium\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 131,
    "__1": "esomeprazole/naproxen",
    "__2": "Vimovo",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: esomeprazole/naproxen\nBrand Example: Vimovo\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (Proton Pump Inhibitor /NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "eszopiclone",
    "__2": "Lunesta",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.6 (Effective November 1, 2020) \nDrug Formulary \nDrug Ingredient: eszopiclone\nBrand Example: Lunesta\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 days \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines: \nDepressive Disorders: Recommended"
  },
  {
    "": 132,
    "__1": "estradiol",
    "__2": "Climara, Estraderm",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: estradiol\nBrand Example: Climara, Estraderm\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Estrogens\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 133,
    "__1": "etanercept",
    "__2": "Enbrel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: etanercept\nBrand Example: Enbrel\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines: \nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 134,
    "__1": "etidronate disodium",
    "__2": "Didronel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: etidronate disodium\nBrand Example: Didronel\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines: \nHip and Groin Disorders: Recommended, No Recommendation \nKnee Disorders: No Recommendation \nLow Back Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 135,
    "__1": "etodolac",
    "__2": "Lodine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: etodolac\nBrand Example: Lodine\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 136,
    "__1": "famciclovir",
    "__2": "Famvir",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: famciclovir\nBrand Example: Famvir\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antivirals\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 137,
    "__1": "famotidine",
    "__2": "Pepcid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: famotidine\nBrand Example: Pepcid\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (H2 receptor blocker) \nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 138,
    "__1": "famotidine/ibuprofen",
    "__2": "Duexis",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: famotidine/ibuprofen\nBrand Example: Duexis\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (H2 Receptor Blocker /NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 139,
    "__1": "fenoprofen calcium",
    "__2": "Nalfon",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fenoprofen calcium\nBrand Example: Nalfon\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 140,
    "__1": "fentanyl",
    "__2": "Duragesic",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: fentanyl\nBrand Example: Duragesic\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 141,
    "__1": "fentanyl citrate oral transmucosal",
    "__2": "Actiq, Fentora",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: fentanyl citrate oral transmucosal\nBrand Example: Actiq, Fentora\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 142,
    "__1": "fluconazole",
    "__2": "Diflucan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluconazole\nBrand Example: Diflucan\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 143,
    "__1": "flunisolide",
    "__2": "Aerospan HFA",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: flunisolide\nBrand Example: Aerospan HFA\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 144,
    "__1": "fluocinolone acetonide",
    "__2": "Synalar",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluocinolone acetonide\nBrand Example: Synalar\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 145,
    "__1": "fluocinonide",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluocinonide\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Elbow Disorders: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 146,
    "__1": "fluorometholone",
    "__2": "FML",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluorometholone\nBrand Example: FML\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 147,
    "__1": "fluoxetine hcl",
    "__2": "Prozac",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: fluoxetine hcl\nBrand Example: Prozac\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Recommended, Not Recommended; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Recommended, Not Recommended \nLow Back Disorders: Not Recommended \nPost-Traumatic Stress Disorder: Recommended \nShoulder: Not Recommended, Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "fluvastatin sodium er",
    "__2": "Lescol XL",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: fluvastatin sodium er\nBrand Example: Lescol XL\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-hyperlipidemic\nReference in ACOEM Guidelines: \nShoulder Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 148,
    "__1": "flurbiprofen",
    "__2": "Ansaid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: flurbiprofen\nBrand Example: Ansaid\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 149,
    "__1": "flurbiprofen sodium",
    "__2": "Ocufen",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: flurbiprofen sodium\nBrand Example: Ocufen\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Inflammatory (NSAID) Ophthalmic Drops\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 150,
    "__1": "fluticasone propionate",
    "__2": "Flovent",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluticasone propionate\nBrand Example: Flovent\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 151,
    "__1": "fluticasone prop (topical)",
    "__2": "Cutivate",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluticasone prop (topical)\nBrand Example: Cutivate\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 152,
    "__1": "fluticasone-salmeterol",
    "__2": "Advair",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluticasone-salmeterol\nBrand Example: Advair\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 153,
    "__1": "fluvoxamine maleate",
    "__2": "Luvox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fluvoxamine maleate\nBrand Example: Luvox\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Recommended, Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nPost-Traumatic Stress Disorder: No Recommendation \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 154,
    "__1": "folic acid",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: folic acid\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hematopoietic Agents\nReference in ACOEM Guidelines: Cervical and Thoracic Spine Disorders: Not Recommended ; Depressive Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 155,
    "__1": "fondaparinux sodium",
    "__2": "Arixtra",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: fondaparinux sodium\nBrand Example: Arixtra\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: No Recommendation \nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 156,
    "__1": "formoterol fumarate",
    "__2": "Foradil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: formoterol fumarate\nBrand Example: Foradil\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 157,
    "__1": "formoterol/mometasone",
    "__2": "Dulera",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: formoterol/mometasone\nBrand Example: Dulera\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 158,
    "__1": "frovatriptan succinate",
    "__2": "Frova",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: frovatriptan succinate\nBrand Example: Frova\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 159,
    "__1": "gabapentin",
    "__2": "Neurontin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: gabapentin\nBrand Example: Neurontin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: 4 Days\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended, No Recommendation \nChronic Pain: Recommended\nHip and Groin Disorders: Recommended, No Recommendation \nKnee Disorders: Recommended, Not Recommended, No Recommendation \nLow Back Disorders: Recommended, No Recommendation \nPost-Traumatic Stress Disorder: Not Recommended \nShoulder: Recommended, Not Recommended, No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 160,
    "__1": "gabapentin (once-daily)",
    "__2": "Gralise",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: gabapentin (once-daily)\nBrand Example: Gralise\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended \nHip and Groin Disorders: Not Recommended \nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 161,
    "__1": "gabapentin enacarbil",
    "__2": "Horizant",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: gabapentin enacarbil\nBrand Example: Horizant\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines: \nChronic Pain: Recommended, Not Recommended \nHip and Groin Disorders: Not Recommended \nPost-Traumatic Stress Disorder: Not Recommended \nShoulder Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 162,
    "__1": "gatifloxacin",
    "__2": "Zymaxid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: gatifloxacin\nBrand Example: Zymaxid\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 163,
    "__1": "gentamicin (topical)",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: gentamicin (topical)\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 164,
    "__1": "gentamicin sulfate ophthalmic",
    "__2": "Gentak",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: gentamicin sulfate ophthalmic\nBrand Example: Gentak\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 165,
    "__1": "glucosamine sulfate",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: glucosamine sulfate\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines (OTC nutraceutical)\nReference in ACOEM Guidelines: \nHand, Wrist, and Forearm Disorders: No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nShoulder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 166,
    "__1": "golimumab",
    "__2": "Simponi",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: golimumab\nBrand Example: Simponi\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines: \nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 167,
    "__1": "guanfacine er",
    "__2": "Intuniv",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: guanfacine er\nBrand Example: Intuniv\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: ADHD/Anti-Narcolepsy/Anti-Obesity/Anorexiants\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 168,
    "__1": "guanfacine hcl",
    "__2": "Tenex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: guanfacine hcl\nBrand Example: Tenex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 169,
    "__1": "heparin sodium",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: heparin sodium\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 170,
    "__1": "homatropine hbr ophthalmic",
    "__2": "Isopto Homatropine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: homatropine hbr ophthalmic\nBrand Example: Isopto Homatropine\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines: Eye: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 171,
    "__1": "hydrochlorothiazide",
    "__2": "Microzide",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: hydrochlorothiazide\nBrand Example: Microzide\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Diuretics\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 172,
    "__1": "hydrocodone bitartrate",
    "__2": "Zohydro ER, Hysingla ER",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: hydrocodone bitartrate\nBrand Example: Zohydro ER, Hysingla ER\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 173,
    "__1": "hydrocodone/acetaminophen",
    "__2": "Norco, Vicodin, Xodol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: hydrocodone/acetaminophen\nBrand Example: Norco, Vicodin, Xodol\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended \nElbow Disorders: Recommended, Not Recommended \nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended \nHip and Groin Disorders: Recommended, Not Recommended \nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 174,
    "__1": "hydrocodone/ibuprofen",
    "__2": "Vicoprofen",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: hydrocodone/ibuprofen\nBrand Example: Vicoprofen\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 175,
    "__1": "hydrocortisone",
    "__2": "Cortef",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: hydrocortisone\nBrand Example: Cortef\nExempt/Non-Exempt: Exempt\nSpecial Fill: NA\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended; (R) COVID-19 Coronavirus\nElbow Disorders: No Recommendation \nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation \nHip and Groin Disorders: Not Recommended \nKnee Disorders: No Recommendation \nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation \nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 176,
    "__1": "hydrocortisone (topical)",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: hydrocortisone (topical)\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 177,
    "__1": "hydrocortisone valerate",
    "__2": "Westcort",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: hydrocortisone valerate\nBrand Example: Westcort\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 178,
    "__1": "hydromorphone hcl",
    "__2": "Dilaudid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: hydromorphone hcl\nBrand Example: Dilaudid\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 179,
    "__1": "ibandronate sodium",
    "__2": "Boniva",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: ibandronate sodium\nBrand Example: Boniva\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines: \nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation \nLow Back Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 180,
    "__1": "ibuprofen",
    "__2": "Motrin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ibuprofen\nBrand Example: Motrin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 181,
    "__1": "imipramine hcl",
    "__2": "Tofranil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: imipramine hcl\nBrand Example: Tofranil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders:No Recommendation \nKnee Disorders: Not Recommended\nLow Back Disorders: Recommended, No Recommendation \nPost-Traumatic Stress Disorder: No Recommendation \nShoulder: Not Recommended, Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 182,
    "__1": "indomethacin",
    "__2": "Indocin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: indomethacin\nBrand Example: Indocin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 183,
    "__1": "inositol",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: inositol\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Nutrients\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 184,
    "__1": "irrigating Eye:wash",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: irrigating Eye:wash\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 185,
    "__1": "itraconazole",
    "__2": "Sporanox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: itraconazole\nBrand Example: Sporanox\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 186,
    "__1": "ketoconazole",
    "__2": "Nizoral",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ketoconazole\nBrand Example: Nizoral\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 187,
    "__1": "ketoprofen",
    "__2": "Oruvail",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ketoprofen\nBrand Example: Oruvail\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 188,
    "__1": "ketorolac tromethamine",
    "__2": "Toradol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: ketorolac tromethamine\nBrand Example: Toradol \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 189,
    "__1": "ketorolac tromethamine ophthalmic",
    "__2": "Acular",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ketorolac tromethamine ophthalmic\nBrand Example: Acular\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 190,
    "__1": "ketotifen fumarate",
    "__2": "Zaditor",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ketotifen fumarate\nBrand Example: Zaditor\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 191,
    "__1": "lamotrigine",
    "__2": "Lamictal",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: lamotrigine\nBrand Example: Lamictal\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 192,
    "__1": "lansoprazole",
    "__2": "Prevacid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: lansoprazole\nBrand Example: Prevacid\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended \nTraumatic Brain Injury: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 193,
    "__1": "lenalidomide",
    "__2": "Revlimid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: lenalidomide\nBrand Example: Revlimid\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Miscellaneous Therapeutic Classes\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 194,
    "__1": "levalbuterol",
    "__2": "Xopenex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: levalbuterol\nBrand Example: Xopenex\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 195,
    "__1": "levetiracetam",
    "__2": "Keppra",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: levetiracetam\nBrand Example: Keppra\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 196,
    "__1": "levofloxacin",
    "__2": "Levaquin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: levofloxacin\nBrand Example: Levaquin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended \nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 197,
    "__1": "levofloxacin ophthalmic solution",
    "__2": "Quixin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: levofloxacin ophthalmic solution\nBrand Example: Quixin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 198,
    "__1": "levomilnacipran",
    "__2": "Fetzima",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: levomilnacipran\nBrand Example: Fetzima\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SNRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 199,
    "__1": "levorphanol tartrate",
    "__2": "Levo-Dromoran",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: levorphanol tartrate\nBrand Example: Levo-Dromoran\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 200,
    "__1": "lidocaine",
    "__2": "Lidoderm",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: lidocaine\nBrand Example: Lidoderm\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals \nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, No Recommendation\nElbow Disorders: No Recommendation \nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended, No Recommendation\nShoulder Disorders: Recommended, No Recommendation, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 201,
    "__1": "lidocaine hcl",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: lidocaine hcl\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Cervical and Thoracic Spine Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 202,
    "__1": "lidocaine hcl ophth",
    "__2": "Akten",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: lidocaine hcl ophth\nBrand Example: Akten\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Opthalmic Agents\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 203,
    "__1": "lidocaine/prilocaine",
    "__2": "Emla",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: lidocaine/prilocaine\nBrand Example: Emla\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 204,
    "__1": "lithium carbonate",
    "__2": "Lithobid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: lithium carbonate\nBrand Example: Lithobid\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 205,
    "__1": "lodoxamide ophth",
    "__2": "Alomide",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: lodoxamide ophth\nBrand Example: Alomide\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 206,
    "__1": "loratadine",
    "__2": "Claritin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: loratadine\nBrand Example: Claritin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 207,
    "__1": "lorazepam",
    "__2": "Ativan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: lorazepam\nBrand Example: Ativan\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 208,
    "__1": "loteprednol etabonate ophthalmic",
    "__2": "Alrex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: loteprednol etabonate ophthalmic\nBrand Example: Alrex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 209,
    "__1": "magnesium",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: magnesium\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Minerals and Electrolytes\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 210,
    "__1": "maprotiline hcl",
    "__2": "Ludiomil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: maprotiline hcl\nBrand Example: Ludiomil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation \nKnee Disorders: Not Recommended, No Recommendation \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended, Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 211,
    "__1": "meclofenamate sodium",
    "__2": "Meclomen",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: meclofenamate sodium\nBrand Example: Meclomen\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 212,
    "__1": "medroxyprogesterone",
    "__2": "Provera",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: medroxyprogesterone\nBrand Example: Provera\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Progestins\nReference in ACOEM Guidelines: Traumatic Brain Injury: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 213,
    "__1": "mefenamic acid",
    "__2": "Ponstel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: mefenamic acid\nBrand Example: Ponstel\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 214,
    "__1": "melatonin",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: melatonin\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines: Chronic Pain: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 215,
    "__1": "meloxicam",
    "__2": "Mobic",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: meloxicam\nBrand Example: Mobic\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 216,
    "__1": "memantine hcl",
    "__2": "Namenda",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: memantine hcl\nBrand Example: Namenda\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\n (NDMA Receptor Antagonist)\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended, No Recommendation \nLow Back Disorders: Not Recommended \nTraumatic Brain Injury:No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 217,
    "__1": "menthol",
    "__2": "Bengay Ultra, Biofreeze",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: menthol\nBrand Example: Bengay Ultra, Biofreeze\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: No Recommendation\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 218,
    "__1": "meperidine hcl",
    "__2": "Demerol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: meperidine hcl\nBrand Example: Demerol\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 219,
    "__1": "metaxalone",
    "__2": "Skelaxin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: metaxalone\nBrand Example: Skelaxin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Not Recommended \nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 220,
    "__1": "methadone hcl",
    "__2": "Dolophine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: methadone hcl\nBrand Example: Dolophine\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 221,
    "__1": "methocarbamol",
    "__2": "Robaxin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: methocarbamol\nBrand Example: Robaxin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Not Recommended \nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 222,
    "__1": "methyl salicylate",
    "__2": "Bengay Ultra",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: methyl salicylate\nBrand Example: Bengay Ultra\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: No Recommendation \nChronic Pain: No Recommendation \nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 223,
    "__1": "methylphenidate hydrochloride",
    "__2": "Ritalin, Concerta",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: methylphenidate hydrochloride\nBrand Example: Ritalin, Concerta\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: ADHD / Anti-narcolepsy / Anti-Obesity / Anorexiants\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 224,
    "__1": "methylprednisolone",
    "__2": "Medrol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: methylprednisolone\nBrand Example: Medrol\nExempt/Non-Exempt: Exempt\nSpecial Fill: NA\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended ; (R) COVID-19 Coronavirus \nElbow Disorders: No Recommendation \nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation \nHip and Groin Disorders: Not Recommended \nLow Back Disorders: Recommended, Not Recommended, No Recommendation \nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended \nTraumatic Brain Injury: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 225,
    "__1": "methylsulfonylmethane",
    "__2": "MSM",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: methylsulfonylmethane\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals (OTC nutraceuticals)\nReference in ACOEM Guidelines: \nHip and Groin Disorders: No Recommendation \nKnee Disorders: No Recommendation \nShoulder: No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 226,
    "__1": "metronidazole",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: metronidazole \nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 227,
    "__1": "metronidazole oral",
    "__2": "Flagyl",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: metronidazole oral\nBrand Example: Flagyl\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 228,
    "__1": "miconazole nitrate",
    "__2": "Micatin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: miconazole nitrate\nBrand Example: Micatin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 229,
    "__1": "midazolam hcl",
    "__2": "Versed",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: midazolam hcl\nBrand Example: Versed\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 230,
    "__1": "milnacipran",
    "__2": "Savella",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: milnacipran\nBrand Example: Savella\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc. (Anti-depressant)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Recommended, Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 231,
    "__1": "minocycline hcl",
    "__2": "Minocin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: minocycline hcl\nBrand Example: Minocin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Tetracyclines) \nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 232,
    "__1": "mirtazapine",
    "__2": "Remeron",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: mirtazapine\nBrand Example: Remeron\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines: \nChronic Pain: Recommended ; Depressive Disorders: Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 233,
    "__1": "misoprostol",
    "__2": "Cytotec",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: misoprostol\nBrand Example: Cytotec\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended \nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 234,
    "__1": "modafinil",
    "__2": "Provigil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: modafinil\nBrand Example: Provigil\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: ADHD / Anti-narcolepsy / Anti-Obesity / Anorexiants\nReference in ACOEM Guidelines: Traumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 235,
    "__1": "mometasone furoate (topical)",
    "__2": "Elocon",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: mometasone furoate (topical)\nBrand Example: Elocon\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 236,
    "__1": "mometasone furoate",
    "__2": "Asmanex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: mometasone furoate\nBrand Example: Asmanex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 237,
    "__1": "montelukast sodium",
    "__2": "Singluair",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: montelukast sodium\nBrand Example: Singluair\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 238,
    "__1": "morphine sulfate",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: morphine sulfate\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 239,
    "__1": "morphine sulfate extended release",
    "__2": "MS Contin, Kadian, Avinza",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: morphine sulfate extended release\nBrand Example: MS Contin, Kadian, Avinza\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 240,
    "__1": "morphine/naltrexone",
    "__2": "Embeda",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: morphine/naltrexone\nBrand Example: Embeda\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 241,
    "__1": "moxifloxacin hcl",
    "__2": "Avelox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: moxifloxacin hcl\nBrand Example: Avelox\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 242,
    "__1": "moxifloxacin hcl ophthalmic",
    "__2": "Vigamox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: moxifloxacin hcl ophthalmic\nBrand Example: Vigamox\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 243,
    "__1": "mupirocin",
    "__2": "Bactroban",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: mupirocin\nBrand Example: Bactroban\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 244,
    "__1": "nabilone",
    "__2": "Cesamet",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: nabilone\nBrand Example: Cesamet\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: No Recommendation ; Depressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 245,
    "__1": "nabumetone",
    "__2": "Relafen",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: nabumetone\nBrand Example: Relafen\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 246,
    "__1": "n-acetyl-l-cysteine",
    "__2": "NAC",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: n-acetyl-l-cysteine\nBrand Example: NAC\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Nutrients\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended \nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 247,
    "__1": "naloxone hcl",
    "__2": "Evzio, Narcan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: naloxone hcl\nBrand Example: Evzio, Narcan\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidotes and Specific Antagonists\nReference in ACOEM Guidelines: Opioid: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 248,
    "__1": "naproxen",
    "__2": "Aleve, Naprosyn",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: naproxen\nBrand Example: Aleve, Naprosyn\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation \nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 249,
    "__1": "naratriptan hcl",
    "__2": "Amerge",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: naratriptan hcl\nBrand Example: Amerge\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 250,
    "__1": "natamycin ophth",
    "__2": "Natacyn",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: natamycin ophth\nBrand Example: Natacyn\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 251,
    "__1": "nedocromil",
    "__2": "Alocril",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: nedocromil\nBrand Example: Alocril\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophtalmic Agents\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 252,
    "__1": "nefazodone hcl",
    "__2": "Serzone",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: nefazodone hcl\nBrand Example: \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: Recommended; Depressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 253,
    "__1": "neomycin sulfate",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: neomycin sulfate\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 254,
    "__1": "neomycin/polymyxin b/bacitracin",
    "__2": "Neosporin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: neomycin/polymyxin b/bacitracin\nBrand Example: Neosporin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 255,
    "__1": "nifedipine",
    "__2": "Procardia",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: nifedipine\nBrand Example: Procardia\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Calcium Channel Blockers\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 256,
    "__1": "nitroglycerin transdermal",
    "__2": "Nitro-Dur",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: nitroglycerin transdermal\nBrand Example: Nitro-Dur\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antianginal Agents (Glyceril trinitrate patches)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 257,
    "__1": "nizatidine",
    "__2": "Axid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: nizatidine\nBrand Example: Axid\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (H2 receptor blocker) \nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 258,
    "__1": "nortriptyline hcl",
    "__2": "Pamelor",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: nortriptyline hcl\nBrand Example: Pamelor\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation \nKnee Disorders: Recommended, Not Recommended, No Recommendation \nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 259,
    "__1": "nystatin/triamcinolone",
    "__2": "Mycolog II",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: nystatin/triamcinolone\nBrand Example: Mycolog II\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 260,
    "__1": "olanzapine",
    "__2": "Zyprexa",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: olanzapine\nBrand Example: Zyprexa\nExempt/Non-Exempt: Exempt\nSpecial Fill: not applicable\nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines: Depressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 261,
    "__1": "ofloxacin",
    "__2": "Floxin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ofloxacin\nBrand Example: Floxin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Fluoroquinolones\nReference in ACOEM Guidelines: Hip and Groin Disorders: Recommended.\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 262,
    "__1": "ofloxacin ophthalmic solution",
    "__2": "Ocuflox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ofloxacin ophthalmic solution\nBrand Example: Ocuflox\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 263,
    "__1": "olopatadine hcl",
    "__2": "Pataday, Patanol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: olopatadine hcl\nBrand Example: Pataday, Patanol\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 264,
    "__1": "omega-3",
    "__2": "Omega-3 Fatty Acids",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: omega-3\nBrand Example: Omega-3 Fatty Acids\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Nutrients\nReference in ACOEM Guidelines: Depressive Disorders: No Recommendation; Post-Traumatic Stress Disorder: No Recommendation; Shoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 265,
    "__1": "omeprazole",
    "__2": "Prilosec",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: omeprazole\nBrand Example: Prilosec\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended \nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 266,
    "__1": "ondansetron",
    "__2": "Zofran ODT",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ondansetron\nBrand Example: Zofran\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation; (R) Antiemetics\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 267,
    "__1": "orphenadrine citrate",
    "__2": "Norflex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: orphenadrine citrate\nBrand Example: Norflex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Not Recommended \nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 268,
    "__1": "oxaprozin",
    "__2": "Daypro",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: oxaprozin\nBrand Example: Daypro\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 269,
    "__1": "oxcarbazepine",
    "__2": "Trileptal",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: oxcarbazepine\nBrand Example: Trileptal\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation \nLow Back Disorders: No Recommendation \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 270,
    "__1": "oxycodone hcl",
    "__2": "OxyContin, Roxicodone",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: oxycodone hcl\nBrand Example: OxyContin, Roxicodone\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended \nElbow Disorders: Recommended, Not Recommended \nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended \nHip and Groin Disorders: Recommended, Not Recommended \nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 271,
    "__1": "oxycodone/acetaminophen",
    "__2": "Percocet",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: oxycodone/acetaminophen\nBrand Example: Percocet\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: 4 days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended \nElbow Disorders: Recommended, Not Recommended \nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended \nHip and Groin Disorders: Recommended, Not Recommended \nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 272,
    "__1": "oxycodone/aspirin",
    "__2": "Percodan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: oxycodone/aspirin\nBrand Example: Percodan\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 273,
    "__1": "oxycodone/ibuprofen",
    "__2": "Combunox",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: oxycodone/ibuprofen\nBrand Example: Combunox\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 274,
    "__1": "oxymorphone hcl",
    "__2": "Opana, Opana ER",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: oxymorphone hcl\nBrand Example: Opana, Opana ER\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 275,
    "__1": "oxytocin",
    "__2": "Pitocin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: oxytocin\nBrand Example: Pitocin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Oxytocics\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 276,
    "__1": "pantoprazole sodium",
    "__2": "Protonix",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: pantoprazole sodium\nBrand Example: Protonix\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended \nTraumatic Brain Injury: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 277,
    "__1": "paroxetine hcl",
    "__2": "Paxil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: paroxetine hcl\nBrand Example: Paxil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Recommended, Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Recommended, Not Recommended \nLow Back Disorders: Not Recommended \nPost-Traumatic Stress Disorder: Recommended \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 278,
    "__1": "penicillin v potassium",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: penicillin v potassium\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines: \nHand, Wrist, and Forearm Disorders: Not Recommended \nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 279,
    "__1": "pentazocine/naloxone hcl",
    "__2": "Talwin NX",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: pentazocine/naloxone hcl\nBrand Example: Talwin NX\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 280,
    "__1": "phenelzine sulfate",
    "__2": "Nardil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: phenelzine sulfate\nBrand Example: Nardil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 281,
    "__1": "phenobarbital",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: phenobarbital\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines: Traumatic Brain Injury: Not Recommended, No Recommendation \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 282,
    "__1": "phenytoin",
    "__2": "Dilantin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: phenytoin\nBrand Example: Dilantin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 283,
    "__1": "piroxicam",
    "__2": "Feldene",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: piroxicam\nBrand Example: Feldene\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "pitavastatin calcium",
    "__2": "Livalo",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: pitavastatin calcium\nBrand Example: Livalo\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-hyperlipidemics\nReference in ACOEM Guidelines: \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "pitavastatin magnesium",
    "__2": "Zypitamag",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: pitavastatin magnesium\nBrand Example: Zypitamag\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-hyperlipidemics\nReference in ACOEM Guidelines: \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "pravastatin sodium",
    "__2": "Pravachol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: pravastatin sodium\nBrand Example: Pravachol\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-hyperlipidemics\nReference in ACOEM Guidelines: \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 284,
    "__1": "pramipexole dihydrochloride",
    "__2": "Mirapex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: pramipexole dihydrochloride\nBrand Example: Mirapex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiparkinson and Related Therapy Agents\nReference in ACOEM Guidelines: Chronic Pain: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 285,
    "__1": "prazosin hcl",
    "__2": "Minpress",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: prazosin hcl\nBrand Example: Minpress\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antihypertensives\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 286,
    "__1": "prednicarbate",
    "__2": "Dermatop",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: prednicarbate\nBrand Example: Dermatop\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 287,
    "__1": "prednisolone",
    "__2": "Orapred",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: prednisolone\nBrand Example: Orapred\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation \nHip and Groin Disorders: Not Recommended \nLow Back Disorders: Recommended, Not Recommended, No Recommendation \nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 288,
    "__1": "prednisolone acetate",
    "__2": "Pred Forte, Pred Mild",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: prednisolone acetate\nBrand Example: Pred Forte, Pred Mild\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 289,
    "__1": "prednisolone sodium ophth",
    "__2": "Omnipred",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: prednisolone sodium ophth\nBrand Example: Omnipred\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 290,
    "__1": "prednisone",
    "__2": "Sterapred",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: prednisone\nBrand Example: Sterapred\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable \nDrug Class: Corticosteroids\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation \nHip and Groin Disorders: Not Recommended \nLow Back Disorders: Recommended, Not Recommended, No Recommendation \nShoulder: Recommended, Not Recommended, No Recommendation \nWork Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 291,
    "__1": "pregabalin",
    "__2": "Lyrica",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: pregabalin\nBrand Example: Lyrica\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: No Recommendation \nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation \nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 292,
    "__1": "pregabalin (once-daily)",
    "__2": "Lyrica CR",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: pregabalin (once-daily)\nBrand Example: Lyrica CR\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended \nHip and Groin Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 293,
    "__1": "probenecid",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: probenecid\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Gout Agents\nReference in ACOEM Guidelines: Hip and Groin Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 294,
    "__1": "progesterone",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: progesterone\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Progestins\nReference in ACOEM Guidelines: Traumatic Brain Injury: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 295,
    "__1": "proparacaine hcl",
    "__2": "Alcaine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: proparacaine hcl\nBrand Example: Alcaine\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anesthetic)\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 296,
    "__1": "propranolol hcl",
    "__2": "Inderal",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: propranolol hcl\nBrand Example: Inderal\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Beta Blockers\nReference in ACOEM Guidelines: \nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 297,
    "__1": "protriptyline hcl",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: protriptyline hcl\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (TCAs)\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended; Depressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 298,
    "__1": "pyridostigmine bromide",
    "__2": "Mestinon",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: pyridostigmine bromide\nBrand Example: Mestinon\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antimyasthenic / Cholinergic Agents\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 299,
    "__1": "quetiapine fumarate",
    "__2": "Seroquel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: quetiapine fumarate\nBrand Example: Seroquel\nExempt/Non-Exempt: Exempt\nSpecial Fill: NA\nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines: \nChronic Pain: No Recommendation ; Depressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 300,
    "__1": "rabeprazole sodium",
    "__2": "Aciphex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: rabeprazole sodium\nBrand Example: Aciphex\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended \nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 301,
    "__1": "raloxifene hydrochloride",
    "__2": "Evista",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: raloxifene hydrochloride\nBrand Example: Evista\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. \nReference in ACOEM Guidelines: Chronic Pain: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 302,
    "__1": "ranitidine hcl",
    "__2": "Zantac",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ranitidine hcl\nBrand Example: Zantac\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs (H2 receptor blocker) \nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHand, Wrist, and Forearm Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended \nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 303,
    "__1": "regular insulin",
    "__2": "Humulin R",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: regular insulin\nBrand Example: Humulin R\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidiabetics\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended \nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 304,
    "__1": "risedronate sodium",
    "__2": "Actonel",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: risedronate sodium\nBrand Example: Actonel\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate) \nReference in ACOEM Guidelines: \nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation \nLow Back Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "rosuvastatin calcium",
    "__2": "Crestor",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: rosuvastatin calcium\nBrand Example: Crestor\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-hyperlipidemics\nReference in ACOEM Guidelines: \nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 305,
    "__1": "risperidone",
    "__2": "Risperdal",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: risperidone\nBrand Example: Risperdal\nExempt/Non-Exempt: Exempt\nSpecial Fill: NA\nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines: Depressive Disorders: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 306,
    "__1": "rivaroxaban",
    "__2": "Xarelto",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: rivaroxaban\nBrand Example: Xarelto\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 307,
    "__1": "rivastigmine tartrate",
    "__2": "Exelon",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: rivastigmine tartrate\nBrand Example: Exelon\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 308,
    "__1": "rizatriptan benzoate",
    "__2": "Maxalt",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: rizatriptan benzoate\nBrand Example: Maxalt\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 309,
    "__1": "s-adenosylmethionine",
    "__2": "SAM E",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: s-adenosylmethionine\nBrand Example: SAM E\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 310,
    "__1": "salmeterol",
    "__2": "Serevent",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: salmeterol\nBrand Example: Serevent\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 311,
    "__1": "salsalate",
    "__2": "Disalcid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: salsalate\nBrand Example: Disalcid\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - NonNarcotic (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 312,
    "__1": "sertraline hcl",
    "__2": "Zoloft",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: sertraline hcl\nBrand Example: Zoloft\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Recommended, Not Recommended \nHip and Groin Disorders: Not Recommended \nKnee Disorders: Recommended, Not Recommended \nLow Back Disorders: Not Recommended \nPost-Traumatic Stress Disorder: Recommended \nShoulder: Not Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 313,
    "__1": "silver sulfadiazine",
    "__2": "Silvadene",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: silver sulfadiazine\nBrand Example: Silvadene\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 314,
    "__1": "sodium chloride ophthalmic",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: sodium chloride ophthalmic\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 315,
    "__1": "sodium oxybate",
    "__2": "Xyrem",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: sodium oxybate\nBrand Example: Xyrem\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\nReference in ACOEM Guidelines: Chronic Pain: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 316,
    "__1": "sucralfate",
    "__2": "Carafate",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: sucralfate\nBrand Example: Carafate\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ulcer Drugs\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended \nElbow Disorders: Recommended \nHip and Groin Disorders: Recommended \nKnee Disorders: Recommended \nLow Back Disorders: Recommended \nShoulder: Recommended \nTraumatic Brain Injury: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 317,
    "__1": "sulfamethoxazole/trimethoprim",
    "__2": "Bactrim",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: sulfamethoxazole/trimethoprim\nBrand Example: Bactrim\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 318,
    "__1": "sulindac",
    "__2": "Clinoril",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: sulindac\nBrand Example: Clinoril\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 319,
    "__1": "sumatriptan succinate",
    "__2": "Imitrex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: sumatriptan succinate\nBrand Example: Imitrex\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 320,
    "__1": "tacrolimus",
    "__2": "Protopic",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tacrolimus \nBrand Example: Protopic\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 321,
    "__1": "tapentadol",
    "__2": "Nucynta",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: tapentadol\nBrand Example: Nucynta\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 322,
    "__1": "temazepam",
    "__2": "Restoril",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: temazepam\nBrand Example: Restoril\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines: Post-Traumatic Stress Disorder: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 323,
    "__1": "terbinafine hcl",
    "__2": "Lamisil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: terbinafine hcl\nBrand Example: Lamisil\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antifungals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 324,
    "__1": "terbinafine hcl (topical)",
    "__2": "Lamisil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: terbinafine hcl (topical)\nBrand Example: Lamisil\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 325,
    "__1": "tetracaine hcl",
    "__2": "Tetcaine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tetracaine hcl\nBrand Example: Tetcaine\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anesthetic)\nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 326,
    "__1": "tetracycline hcl",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tetracycline hcl\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Tetracyclines \nReference in ACOEM Guidelines: Eye: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 327,
    "__1": "thalidomide",
    "__2": "Thalomid",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: thalidomide\nBrand Example: Thalomid\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Assorted Classes\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended \nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 328,
    "__1": "theophylline",
    "__2": "Theo-24, Theo-Dur",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: theophylline\nBrand Example: Theo-24, Theo-Dur\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 329,
    "__1": "tiagabine hcl",
    "__2": "Gabitril",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: tiagabine hcl\nBrand Example: Gabitril\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended \nHip and Groin Disorders: Not Recommended \nLow Back Disorders: No Recommendation \nPost-Traumatic Stress Disorder: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 330,
    "__1": "tizanidine hcl",
    "__2": "Zanaflex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: tizanidine hcl\nBrand Example: Zanaflex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: Not Applicable \nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended, No Recommendation \nHip and Groin Disorders: Recommended \nKnee Disorders: Not Recommended, No Recommendation \nLow Back Disorders: Recommended, Not Recommended \nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 331,
    "__1": "tobramycin ophthalmic",
    "__2": "Tobrex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tobramycin ophthalmic\nBrand Example: Tobrex\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines: Eye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 332,
    "__1": "tolnaftate",
    "__2": "Tinactin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tolnaftate\nBrand Example: Tinactin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 333,
    "__1": "tolmetin sodium",
    "__2": "Tolectin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tolmetin sodium\nBrand Example: Tolectin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 334,
    "__1": "topiramate",
    "__2": "Topamax",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: topiramate\nBrand Example: Topamax\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 335,
    "__1": "tramadol hcl",
    "__2": "Ultram",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: tramadol hcl\nBrand Example: Ultram, Ultram ER\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended \nElbow Disorders: Recommended, Not Recommended \nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended \nHip and Groin Disorders: Recommended, Not Recommended \nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 336,
    "__1": "tramadol hcl/acetaminopehn",
    "__2": "Ultracet",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: tramadol hcl/ac\nBrand Example: Ultracet\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Recommended, Not Recommended \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended, Not Recommended \nElbow Disorders: Recommended, Not Recommended \nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended \nHip and Groin Disorders: Recommended, Not Recommended \nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 337,
    "__1": "tranexamic acid",
    "__2": "Lysteda",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tranexamic acid\nBrand Example: Lysteda\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hemostatics\nReference in ACOEM Guidelines: \nEye: Recommended \nTraumatic Brain Injury: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 338,
    "__1": "trazodone hcl",
    "__2": "Desyrel, Oleptro",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: trazodone hcl\nBrand Example: Desyrel, Oleptro\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Recommended, Not Recommended, No Recommendation \nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended \nPost-Traumatic Stress Disorder: No Recommendation \nShoulder: Not Recommended, Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 339,
    "__1": "triamcinolone acetonide i",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: triamcinolone acetonide i\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 340,
    "__1": "trolamine salicylate",
    "__2": "Arthricream",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: trolamine salicylate\nBrand Example: Arthricream\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Dermatologicals\nReference in ACOEM Guidelines: Hand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 341,
    "__1": "tropicamide ophthalmic",
    "__2": "Mydriacyl",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: tropicamide ophthalmic\nBrand Example: Mydriacyl\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines: Eye: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 342,
    "__1": "trypsin",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: trypsin\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Chemicals (Proteolytic enzyme)\nReference in ACOEM Guidelines: Ankle and Foot Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 343,
    "__1": "valacyclovir hcl",
    "__2": "Valtrex",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: valacyclovir hcl\nBrand Example: Valtrex\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antivirals\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 344,
    "__1": "valproic acid",
    "__2": "Depakote, Depakene, Depacon",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: valproic acid\nBrand Example: Depakote, Depakene, Depacon\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended \nHip and Groin Disorders: Not Recommended \nLow Back Disorders: No Recommendation \nPost-Traumatic Stress Disorder: Not Recommended \nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 345,
    "__1": "venlafaxine hcl",
    "__2": "Effexor",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: venlafaxine hcl\nBrand Example: Effexor\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SNRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Recommended, Not Recommended \nChronic Pain: Recommended \nHip and Groin Disorders: No Recommendation \nKnee Disorders: Recommended, Not Recommended, No Recommendation \nLow Back Disorders: Recommended, No Recommendation \nPost-Traumatic Stress Disorder: Recommended \nShoulder: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 346,
    "__1": "vilazodone",
    "__2": "Viibryd",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: vilazodone\nBrand Example: Viibryd\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nChronic Pain: Not Recommended ; Depressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended \nKnee Disorders: Not Recommended \nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 347,
    "__1": "vitamin a",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: vitamin a\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines: Cervical and Thoracic Spine Disorders: Not Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 348,
    "__1": "vitamin b-12",
    "__2": "Cyanocobalamin, Methylcobalamin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: vitamin b-12\nBrand Example: Cyanocobalamin, Methylcobalamin\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Hematopoietic Agents (Vitamins)\nReference in ACOEM Guidelines: \nCervical and Thoracic Spine Disorders: Not Recommended \nElbow Disorders: No Recommendation \nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 349,
    "__1": "vitamin b-6",
    "__2": "Pyridoxine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: vitamin b-6\nBrand Example: Pyridoxine\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 350,
    "__1": "vitamin d",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: vitamin d3\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines: (R) COVID-19 Coronavirus; (X) Depressive Disorders \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 351,
    "__1": "vitamin e",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: vitamin e\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Vitamins\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 352,
    "__1": "warfarin sodium",
    "__2": "Coumadin",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: warfarin sodium\nBrand Example: Coumadin\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: \nDrug Class: Anticoagulants\nReference in ACOEM Guidelines: \nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 353,
    "__1": "zafirlukast",
    "__2": "Accolate",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: zafirlukast\nBrand Example: Accolate\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 354,
    "__1": "zileuton",
    "__2": "Zyflo",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: zileuton\nBrand Example: Zyflo\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines: Work Related Asthma: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 355,
    "__1": "ziprasidone hcl",
    "__2": "Geodon",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: ziprasidone hcl\nBrand Example: Geodon\nExempt/Non-Exempt: Exempt\nSpecial Fill: NA\nPeri-Op: Not Applicable \nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended; Depressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 356,
    "__1": "zolmitriptan",
    "__2": "Zomig",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: zolmitriptan\nBrand Example: Zomig\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Migraine Products\nReference in ACOEM Guidelines: Traumatic Brain Injury: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 357,
    "__1": "zolpidem tartrate",
    "__2": "Ambien",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: zolpidem tartrate\nBrand Example: Ambien\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: Not Applicable \nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines: Chronic Pain: Not Recommended; Depressive Disorders: Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 358,
    "__1": "zonisamide",
    "__2": "Zonegran",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: zonisamide\nBrand Example: Zonegran\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines: \nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "aprepitant",
    "__2": "Emend, Cinvanti",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: aprepitant\nBrand Example: Emend, Cinvanti \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "dimenhydrinate",
    "__2": "Dramamine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: dimenhydrinate\nBrand Example: Dramamine\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "granisetron hcl",
    "__2": "Kytril",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: granisetron hcl \nBrand Example: Kytril\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "meclizine hcl",
    "__2": "Antivert",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: meclizine hcl\nBrand Example: Antivert\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "metoclopramide hcl",
    "__2": "Reglan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: metoclopramide hcl \nBrand Example: Reglan\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "prochlorperazine maleate",
    "__2": "Compazine",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: prochlorperazine maleate \nBrand Example: Compazine\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "promethazine hcl",
    "__2": "Phenergan",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: promethazine hcl \nBrand Example: Phenergan\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "",
    "__2": "",
    "__3": ""
  },
  {
    "": "",
    "__1": "rolapitant",
    "__2": "Varubi",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: rolapitant\nBrand Example: Varubi\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "scopolamine",
    "__2": "Transderm Scop",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024)  \nDrug Formulary \nDrug Ingredient: scopolamine\nBrand Example: Transderm Scop\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Antiemetics\nReference in ACOEM Guidelines: \n(R) Antiemetics \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "baricitinib",
    "__2": "Olumiant",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline\nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary\nDrug Ingredient: baricitinib\nBrand Example: Olumiant\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - AntiInflammatory\nReference in ACOEM Guidelines:\n(R) COVID-19 Coronavirus \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "chloroquine phosphate",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline\nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary\nDrug Ingredient: chloroquine phosphate\nBrand Example: Not Applicable \nExempt/Non-Exempt: Non Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antimalarials\nReference in ACOEM Guidelines:\n(X, NR) COVID-19 Coronavirus\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "favipiravir",
    "__2": "",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline\nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary\nDrug Ingredient: favipiravir\nBrand Example: Not Applicable\nExempt/Non-Exempt: Non Exempt\nSpecial Fill: Not Applicable\nPeri-Op:\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\n(X) COVID-19 Coronavirus\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "hydroxychloroquine sulfate",
    "__2": "Plaquenil",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline\nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary\nDrug Ingredient: hydroxychloroquine sulfate\nBrand Example: Plaquenil\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op:Not Applicable\nDrug Class: Antimalarials\nReference in ACOEM Guidelines:\n(R, X, NR) COVID-19 Coronavirus\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "simvastatin",
    "__2": "Zocor",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: simvastatin \nBrand Example: Zocor\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-hyperlipidemics\nReference in ACOEM Guidelines: \nShoulder: Not Recommended\nDepressive Disorder: Recommended \nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "lovastatin",
    "__2": "Mevacor",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February) \nDrug Formulary \nDrug Ingredient: lovastatin\nBrand Example: Mevacor\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-hyperlipidemic\nReference in ACOEM Guidelines: \nShoulder Disorders: No Recommendation\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "lopinavir/ritonavir",
    "__2": "Kaletra",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline\nMTUS Drug List v.11.1 (Effective February 15, 2024)\nDrug Formulary\nDrug Ingredient: lopinavir/ritonavir\nBrand Example: Kaletra\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op:Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\n(X) COVID-19 Coronavirus\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "ivermectin",
    "__2": "Stomectol",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline \nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary \nDrug Ingredient: ivermectin\nBrand Example: Stomectol\nExempt/Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable \nPeri-Op: Not Applicable \nDrug Class: Anti-helmintics\nReference in ACOEM Guidelines: Recommended, Not Recommended\nDosage Form: Not Applicable \nStrength: Not Applicable \nUnique Pharmaceutical Identifier (s): Not Applicable \nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "ribavirin",
    "__2": "Not Applicable",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline\nMTUS Drug List v.11.1 (Effective February 15, 2024)\nDrug Formulary\nDrug Ingredient: ribavirin\nBrand Example: Not Applicable \nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op:Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\n(R) COVID-19 Coronavirus\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": "",
    "__1": "zinc",
    "__2": "",
    "__3": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guideline\nMTUS Drug List v.11.1 (Effective February 15, 2024) \nDrug Formulary\nDrug Ingredient: Zinc\nBrand Example: Not Applicable\nExempt/Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op:Not Applicable\nDrug Class: Minerals & Electrolytes\nReference in ACOEM Guidelines:\n(R) COVID-19 Coronavirus \nACOEM Guidelines Copyright Reed Group Ltd."
  }
]
